LifeMD, Inc.
LFMD· Nasdaq
Filed Aug 7, 2024 · 10-Q · 38 days after period end · 0001493152-24-030564
| Metric | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|---|
| Revenue | $50.66M | $35.95M | $30.46M | $22.31M |
| Net Income | -$6.88M | -$6.73M | -$13.02M | -$16.83M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
LifeMD, Inc. · CIK 948320 · Engraved from SEC EDGAR
ended Jun 30, 2024 · filed Aug 7, 2024 · 38 d after period end